Carried interest is back on the radar of concerns for U.K. biotech, with proposed reforms to how carried interest is taxed threatening to lower the incentive for new VC funds to set up in the U.K. It’s not likely to impact interest in investing in the country’s biotechs, however.
In its Autumn Budget, the Labour government proposed an interim increase in capital gains tax on carried interest to 32% from 28%. The bigger change would arrive in 18 months, when a proposed reform of how carried interest is taxed would come into effect. ...